XILIO THERAPEUTICS

We are using our proprietary platform technology to design and develop tumor-activated immuno-oncology therapies that have the potential to provide effective, tolerable, and durable therapeutic options for patients with solid tumors. We are building a pipeline of novel, tumor-activated molecules, including antibodies, cytokines, bispecifics and cell engagers, that are designed to optimize their therapeutic index and localize anti-tumor activity within the tumor microenvironment... We are committed to transforming cancer treatment by unleashing the full power of highly potent immunotherapies precisely in the tumors. Learn more about Xilio Therapeutics.

Also known as: Xilio Therapeutics, Inc.

Primary location: Waltham United States